Everist Genomics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.everisthealth.com
Clinical Trials
5
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)Brachial Artery Ultrasound Imaging: A Repeatability Study
Not Applicable
Completed
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2016-02-15
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Everist Genomics, Inc
- Target Recruit Count
- 21
- Registration Number
- NCT02682576
- Locations
- 🇺🇸
Yale University Prevention Research Center, Derby, Connecticut, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study
Not Applicable
Completed
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2015-12-29
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Everist Genomics, Inc
- Target Recruit Count
- 20
- Registration Number
- NCT02641197
- Locations
- 🇨🇦
University of Western Ontario, London, Ontario, Canada
🇨🇦Hotel-Dieu Grace Healthcare, Windsor, Ontario, Canada
AngioDefender Versus Brachial Artery Ultrasound Imaging
Not Applicable
Completed
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Everist Genomics, Inc
- Target Recruit Count
- 171
- Registration Number
- NCT02468336
- Locations
- 🇺🇸
University of Colorado, Boulder, Boulder, Colorado, United States
🇺🇸Yale University Prevention Research Center, Derby, Connecticut, United States
🇺🇸Boston University, Boston, Massachusetts, United States
News
No news found